Size Exclusion Chromatography (SEC) HPLC Column Market Report 2026

The size exclusion chromatography (sec) hplc column market size has grown strongly in recent years. It will grow from $0.51 billion in 2025 to $0.56 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to expansion of polymer characterization studies, growth in protein analysis applications, increasing pharmaceutical research activity, wider use of chromatography in academic research, improvements in column manufacturing techniques.

The size exclusion chromatography (sec) hplc column market size is expected to see strong growth in the next few years. It will grow to $0.8 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for biologics characterization, rising investments in analytical instrumentation, expansion of quality control in biopharma manufacturing, growing adoption of advanced chromatography workflows, increasing focus on analytical accuracy and reproducibility. Major trends in the forecast period include increasing demand for high-resolution sec columns, rising use of uhplc-compatible columns, growing adoption in biopharmaceutical analysis, expansion of 2D chromatography applications, enhanced focus on column durability and reproducibility.

The rising demand for personalized medication is expected to drive the growth of the size exclusion chromatography (SEC) HPLC column market in the coming years. Personalized medication involves customizing medical treatment based on an individual’s genetic profile, lifestyle, and health condition to achieve optimal safety and efficacy. The growing need for personalized medication is fueled by advances in genetics and the pursuit of more precise, effective therapies. Size exclusion chromatography (SEC) HPLC columns play a crucial role in analyzing therapeutic proteins’ molecular size and aggregation, ensuring their safety and effectiveness for individualized treatments. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the US Food and Drug Administration (FDA) approved 16 new personalized therapies for rare diseases in 2023, a substantial increase from six approvals in 2022. Therefore, the rising demand for personalized medication is driving the growth of the size exclusion chromatography (SEC) HPLC column market.

Major companies in the size exclusion chromatography (SEC) HPLC column market are focusing on developing advanced solutions, such as multi-attribute quantification methods, to address key challenges in gene therapy development. These methods allow for simultaneous assessment of multiple attributes, improving analytical accuracy and efficiency. For instance, in August 2023, Waters Corporation, a US-based laboratory instruments manufacturer, launched the XBridge Premier GTx BEH SEC columns, specifically designed to enhance analysis and reduce costs in gene therapies, particularly those using adeno-associated viral (AAV) vectors. These columns offer significant advantages, including a 3- to 10-fold reduction in sample requirements, a doubling of analytical speed, and improved sensitivity and resolution. Their innovative design supports process development, formulation analysis, regulatory evaluations, and quality control, enabling faster, more detailed, and cost-effective analysis of AAVs and other large biomolecules, thereby advancing gene therapy research and production.

In May 2023, Waters Corporation, a US-based analytical instruments company, acquired Wyatt Technology Corporation for an undisclosed amount. This acquisition allows Waters to expand its bioanalytical characterization capabilities and strengthen its position in large-molecule and novel modality analysis. Wyatt Technology Corporation, a US-based company, provides light-scattering and field-flow fractionation instruments and software used alongside SEC to characterize the molar mass, size, and interactions of macromolecules and nanoparticles.

Major companies operating in the size exclusion chromatography (sec) hplc column market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, Sartorius AG, PerkinElmer Inc, Shimadzu Corporation, Waters Corporation, Bio Rad Laboratories Inc, Phenomenex Inc, Tosoh Bioscience LLC, Knauer, JASCO Inc, Sepax Technologies Inc, SIELC Technologies, Eprogen Inc, Wyatt Technology, MZ Analysentechnik GmbH, Merck KGaA, Bruker Corporation, Restek Corporation, GL Sciences Inc.

North America was the largest region in the size exclusion chromatography (SEC) HPLC column market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the size exclusion chromatography (sec) hplc column market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the size exclusion chromatography (sec) hplc column market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the sec hplc column market by increasing costs of imported silica materials, polymer resins, precision column hardware, and analytical manufacturing equipment. Pharmaceutical and biotechnology firms in North America and Europe are most affected due to dependence on imported high-performance columns, while Asia-Pacific faces higher production costs for export-oriented column manufacturing. These tariffs are raising instrument operating costs and procurement budgets. However, they are also encouraging regional production of chromatography columns, localized material sourcing, and innovation in cost-efficient column designs.

The size exclusion chromatography (sec) hplc column market research report is one of a series of new reports that provides size exclusion chromatography (sec) hplc column market statistics, including size exclusion chromatography (sec) hplc column industry global market size, regional shares, competitors with a size exclusion chromatography (sec) hplc column market share, detailed size exclusion chromatography (sec) hplc column market segments, market trends and opportunities, and any further data you may need to thrive in the size exclusion chromatography (sec) hplc column industry. This size exclusion chromatography (sec) hplc column market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A size exclusion chromatography (SEC) HPLC column is a chromatographic column specifically designed to separate molecules based on their size in solution. It operates on the principle of molecular sieving, where a porous stationary phase allows smaller molecules to enter the pores and be retained longer, while larger molecules elute more quickly as they are excluded from the pores. This technique is widely used for analyzing and purifying polymers, proteins, and other macromolecules, providing valuable information about molecular weight distribution and aggregation.

The primary types of size exclusion chromatography (SEC) HPLC columns include standard SEC columns, high-resolution SEC columns, ultra-high-performance SEC columns, and 2D SEC columns. Standard SEC columns use a stationary phase to separate molecules primarily by size, offering moderate resolution. These columns are made from various materials, including organic solvents, polymeric materials, silica-based materials, and modified silica particles. They are applied in areas such as biopharmaceutical analysis, protein purification, nucleic acid analysis, and polymer characterization, and are utilized by end users including the pharmaceutical industry, academic and research institutions, biotechnology companies, and environmental testing laboratories.

The size exclusion chromatography (SEC) HPLC column market consists of sales of pre-packed columns, chromatography resins, sample preparation kits, and column fittings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.